206640 — Boditech Med Balance Sheet
0.000.00%
- KR₩381bn
- KR₩343bn
- KR₩138bn
- 77
- 35
- 93
- 80
Annual balance sheet for Boditech Med, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 58,343 | 68,457 | 60,447 | 76,184 | 61,710 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 35,611 | 26,846 | 23,442 | 28,602 | 31,328 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 121,440 | 131,083 | 117,307 | 138,679 | 135,822 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 30,790 | 45,360 | 58,158 | 56,441 | 61,871 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 163,475 | 192,242 | 195,656 | 227,902 | 254,674 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 33,301 | 27,113 | 16,121 | 27,264 | 27,386 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 43,616 | 41,154 | 32,101 | 41,703 | 44,405 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 119,859 | 151,088 | 163,555 | 186,198 | 210,269 |
Total Liabilities & Shareholders' Equity | 163,475 | 192,242 | 195,656 | 227,902 | 254,674 |
Total Common Shares Outstanding |